Your session is about to expire
← Back to Search
Low volume bolus for Labor Pain (CADD2 Trial)
CADD2 Trial Summary
This trial is a randomized, controlled, double-blind study. One hundred parturients will be randomly allocated to receive either PIEB with low-volume bolus (6.25 mL) of a higher local anesthetic concentration solution (0.1% bupivacaine with fentanyl 2.0 mcg/mL) or PIEB with high-volume bolus (10 mL) of lower concentration local anesthetic solution (0.0625% bupivacaine with fentanyl 2.0 mcg/mL). The primary outcome measure is the time to first manual re-dose request. Secondary outcome measures include the
- Labor Pain
- Pain
- Anesthesia
CADD2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CADD2 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor still recruiting participants?
"Affirmative. According to clinicaltrials.gov, this study has been active since it was first published on September 1st 2020 and is actively recruiting participants as of May 6th 2022. Thus far, 400 individuals have been sought at a single medical centre."
How many individuals have committed to participating in this research experiment?
"Affirmative, clinicaltrials.gov data demonstrates that this medical experiment is currently recruiting. It was initially posted on September 1st 2020 and last modified on June 5th 2022. The study hopes to recruit 400 patients from a single healthcare centre."
What risks might patients face with the Low volume bolus procedure?
"Having been approved for public use, low volume bolus is thought to be highly safe and thus was rated a 3 on our team's scale."
Share this study with friends
Copy Link
Messenger